• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病前期和糖尿病对心血管结局的影响。

Impact of pre-diabetes and diabetes on cardiovascular outcomes.

机构信息

Division of Cardiology, Department of Internal Medicine, University of Turin, Corso Dogliotti 14, 10126 Turin, Italy.

出版信息

Curr Vasc Pharmacol. 2012 Nov;10(6):680-3. doi: 10.2174/157016112803520882.

DOI:10.2174/157016112803520882
PMID:23259552
Abstract

The present paper examines major evidences on the correlation between pre-diabetes, diabetes and cardiovascular risk, especially focusing on early and multifactorial treatment strategies holding the potential to delay the occurrence of micro- and macro-vascular complications causing impaired quality of life and reduced survival.

摘要

本文探讨了前驱糖尿病、糖尿病与心血管风险之间的相关性的主要证据,尤其侧重于早期和多因素治疗策略,这些策略有可能延迟导致生活质量受损和存活率降低的微血管和大血管并发症的发生。

相似文献

1
Impact of pre-diabetes and diabetes on cardiovascular outcomes.糖尿病前期和糖尿病对心血管结局的影响。
Curr Vasc Pharmacol. 2012 Nov;10(6):680-3. doi: 10.2174/157016112803520882.
2
Real-world use and modeled impact of glucose-lowering therapies evaluated in recent cardiovascular outcomes trials: An NCDR® Research to Practice project.在最近的心血管结局试验中评估的降糖治疗的真实世界应用和建模影响:NCDR® 研究到实践项目。
Eur J Prev Cardiol. 2017 Oct;24(15):1637-1645. doi: 10.1177/2047487317729252. Epub 2017 Sep 5.
3
Is glycemic control a quinidine-like intervention?血糖控制是一种类似奎尼丁的干预措施吗?
J Diabetes. 2014 Sep;6(5):387-8. doi: 10.1111/1753-0407.12170. Epub 2014 Jul 16.
4
Diabetes: glycated hemoglobin is a marker of diabetes and CVD risk.糖尿病:糖化血红蛋白是糖尿病和心血管疾病风险的标志物。
Nat Rev Cardiol. 2010 Jul;7(7):367-8. doi: 10.1038/nrcardio.2010.84.
5
Intensive glycemic control and cardiovascular disease: an update.强化血糖控制与心血管疾病:最新进展。
Nat Rev Cardiol. 2010 Jul;7(7):369-75. doi: 10.1038/nrcardio.2010.35. Epub 2010 Apr 20.
6
[Comment from the diabetology viewpoint].[糖尿病学视角的评论]
Praxis (Bern 1994). 2008 Aug 27;97(17):943-4. doi: 10.1024/1661-8157.97.17.943.
7
Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials.糖尿病前期受试者研究中糖尿病的预防及主要心血管事件的减少:随机对照临床试验的荟萃分析
Eur J Cardiovasc Prev Rehabil. 2011 Dec;18(6):813-23. doi: 10.1177/1741826711421687. Epub 2011 Aug 30.
8
[Questions for practicing internists].[供实习内科医生练习的问题]
Praxis (Bern 1994). 2008 Aug 27;97(17):945-6. doi: 10.1024/1661-8157.97.17.945.
9
Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease.心血管益处备受关注:将2型糖尿病治疗模式转向对明显心血管疾病患者进行早期联合治疗。
Cardiovasc Diabetol. 2018 Aug 22;17(1):117. doi: 10.1186/s12933-018-0760-6.
10
Decrease mortality in type II diabetes mellitus: glycemic and renal function control.降低2型糖尿病死亡率:血糖和肾功能控制
J Cardiovasc Med (Hagerstown). 2018 Feb;19 Suppl 1:e13-e15. doi: 10.2459/JCM.0000000000000586.

引用本文的文献

1
Hyperhomocysteinemia is associated with decreased apolipoprotein AI levels in normal healthy people.高同型半胱氨酸血症与正常健康人的载脂蛋白AI水平降低有关。
BMC Cardiovasc Disord. 2016 Jan 13;16:10. doi: 10.1186/s12872-016-0186-6.
2
Cardiovascular disease risk prevention: preliminary survey of baseline knowledge, attitude and practices of a nigerian rural community.心血管疾病风险预防:尼日利亚农村社区基线知识、态度及实践的初步调查
N Am J Med Sci. 2014 Sep;6(9):466-71. doi: 10.4103/1947-2714.141644.
3
Effects of reduced β2-glycoprotein I on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice.
β2-糖蛋白I减少对糖尿病小鼠主动脉基质金属蛋白酶及基质金属蛋白酶组织抑制剂表达的影响
BMC Cardiovasc Disord. 2014 Sep 10;14:114. doi: 10.1186/1471-2261-14-114.
4
Small dense low-density lipoprotein as a potential risk factor of nephropathy in type 2 diabetes mellitus.小而密低密度脂蛋白作为2型糖尿病肾病的潜在危险因素
Indian J Endocrinol Metab. 2014 Jan;18(1):94-8. doi: 10.4103/2230-8210.126585.
5
C-reactive protein/oxidised low-density lipoprotein/β2-glycoprotein I complex promotes atherosclerosis in diabetic BALB/c mice via p38mitogen-activated protein kinase signal pathway.C-反应蛋白/氧化型低密度脂蛋白/β2-糖蛋白 I 复合物通过 p38 丝裂原活化蛋白激酶信号通路促进糖尿病 BALB/c 小鼠的动脉粥样硬化。
Lipids Health Dis. 2013 Mar 26;12:42. doi: 10.1186/1476-511X-12-42.